LANIBOS
Tablet, 0.25mg
RxActive license
Active substance (INN)
digoxin
Pharmaceutical form
Pharmaceutical formTablet
Strength0.25mg
PackagingUkupno 20 tableta u blisteru (2x10) u kartonskoj kutiji
ManufacturerBosnalijek d.d., Bosnia and Herzegovina
Therapeutic groupCardiovascular system (C01AA05)
Marketing authorization holderBOSNALIJEK D.D. PREDSTAVNIŠTVO CRNA GORA
Authorization dateNovember 20, 2024
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026